[China Agro Sciences Corp. 101 Xinanyao Street, Jinzhou District, Dalian, Liaoning Province, PRC 116100 September 4, 2009 Division of Corporation Finance 100 F Street, NE Mail Stop 4561 Attn: Mark P. Shuman, Evan S. Jacobson, Barbara C. Jacobs Fax: 703-813-6981 Tel: 202-551-3428 Re: China Agro Sciences Corp. Dear Mr. Shuman I am writing in response to your comment letter dated]
[CALCULATION OF REGISTRATION FEE Title of Securities to be Registered (1) Amount to be Registered (2) Proposed Maximum Offering Price Per Share (3) Proposed Maximumgregate Offering Price (3) Amount of Registration Fee (4) Class A ordinary shares, par value $0.01 per share 15,000,000 (5) $18.8425 $282,637,500.00 $15,771.17 Class A ordinary shares, par value $0.01 per] [Campbells Attorneys-at-Lawotia Centre P.O. Box 884 GrandCaymanKY1-1103YMAN ISLANDS Tel: (345) 949-2648 Fax: (345) 949-8613 SIZE="2">www.campbells.com.ky Your Ref: Our Ref:/zt/15499 DirectEmail:ourtney@campbells.com.ky 1September 2009 SIZE="2">Changyou.com Limited East Tower, Jing Yan Building SIZE="2">No.29 Shijingshan Road, Shijingshan District Beijing 100043 FACE="Times New Roman" SIZE="2">Peoples Republic of China Dear Sirs,mpany Registration Statement] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FACE="Times New Roman" SIZE="2"> PricewaterhouseCoopers Zhong Tian CPAs Limitedmpany Beijing, Peoples Republic of China September4, 2009NSENT OF PRICEWATERHOUSECOOPERS ZHONG TIAN CPAS LIMITEDMPANY dex231.htm 3 EX-23.1]
[China Agro Sciences Corp. 101 Xinanyao Street, Jinzhou District, Dalian, Liaoning Province, PRC 116100 September 4, 2009 Division of Corporation Finance 100 F Street, NE Mail Stop 4561 Attn: Mark P. Shuman, Evan S. Jacobson, Barbara C. Jacobs Fax: 703-813-6981 Tel: 202-551-3428 Re: China Agro Sciences Corp. Dear Mr. Shuman I am writing in response to your comment letter dated]
[ITEM 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS;MPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS. The purpose of the 2009 Stock Option Plan is to enhance the long-term stockholder value of thempany by offering opportunities to directors, officers, employees and eligiblensultants of thempany to acquire and maintain stock ownership in thempany]
[] [[MAPLES AND CALDER LETTERHEAD] Our ref AEO\628564\3415033v2 Direct +852 2971 3081 Email alice.ooi@maplesandcalder.com Wuxi PharmaTech (Cayman) Inc. 288 Fute Zhong Road Waigaoqiao Free Trade Zone Shanghai 200131 People Republic of China 4 September 2009 Dear Sir Wuxi PharmaTech (Cayman) Inc. Company Registration Statement Commission Act Prospectus ADSs Shares Unissued Shares We act as Cayman Islands counsel for Wuxi PharmaTech (Cayman)] [September 4, 2009 WuXi PharmaTech (Cayman) Inc. 288 Fute Zhong Road Waigaoqiao Free Trade Zone Shanghai 200131, PRC Re: American Depositary Shares Representing Ordinary Shares of WuXi PharmaTech (Cayman) Inc. Ladies and Gentlemen: September 4, 2009 - Page 2 The above opinion is provided to the Company for the Companys use in connection with the transactions that are the subject] [Commerce & Finance Law Offices 6F NCI Tower, A12 Jianguomenwai Avenue, Chaoyang District, Beijing, PRC; Postcode: 100022 Tel: (8610) 65693399 Fax: (8610) 65693838, 65693836, 65693837, 65693839 www.tongshang.com.cn E-mail Add: beijing@tongshang.com Website: September 4, 2009 WuXi PharmaTech (Cayman) Inc. 288 Fute Zhong Road Waigaoqiao Free Trade Zone Shanghai 200131 Peoples Republic of China Dear Sirs: For the purposes of giving this] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the incorporation by reference in this Registration Statement on Form F-3 of our reports dated June 25, 2009, relating to the financial statements and financial statement schedule of WuXi PharmaTech (Cayman) Inc., and the effectiveness of WuXi PharmaTech (Cayman) Inc.s internal control over financial reporting, appearing in the Annual Report]
[ITEM 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS;MPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS. The purpose of the 2009 Stock Option Plan is to enhance the long-term stockholder value of thempany by offering opportunities to directors, officers, employees and eligiblensultants of thempany to acquire and maintain stock ownership in thempany]
[] [[MAPLES AND CALDER LETTERHEAD] Our ref AEO\628564\3415033v2 Direct +852 2971 3081 Email alice.ooi@maplesandcalder.com Wuxi PharmaTech (Cayman) Inc. 288 Fute Zhong Road Waigaoqiao Free Trade Zone Shanghai 200131 People Republic of China 4 September 2009 Dear Sir Wuxi PharmaTech (Cayman) Inc. Company Registration Statement Commission Act Prospectus ADSs Shares Unissued Shares We act as Cayman Islands counsel for Wuxi PharmaTech (Cayman)] [September 4, 2009 WuXi PharmaTech (Cayman) Inc. 288 Fute Zhong Road Waigaoqiao Free Trade Zone Shanghai 200131, PRC Re: American Depositary Shares Representing Ordinary Shares of WuXi PharmaTech (Cayman) Inc. Ladies and Gentlemen: September 4, 2009 - Page 2 The above opinion is provided to the Company for the Companys use in connection with the transactions that are the subject] [Commerce & Finance Law Offices 6F NCI Tower, A12 Jianguomenwai Avenue, Chaoyang District, Beijing, PRC; Postcode: 100022 Tel: (8610) 65693399 Fax: (8610) 65693838, 65693836, 65693837, 65693839 www.tongshang.com.cn E-mail Add: beijing@tongshang.com Website: September 4, 2009 WuXi PharmaTech (Cayman) Inc. 288 Fute Zhong Road Waigaoqiao Free Trade Zone Shanghai 200131 Peoples Republic of China Dear Sirs: For the purposes of giving this] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the incorporation by reference in this Registration Statement on Form F-3 of our reports dated June 25, 2009, relating to the financial statements and financial statement schedule of WuXi PharmaTech (Cayman) Inc., and the effectiveness of WuXi PharmaTech (Cayman) Inc.s internal control over financial reporting, appearing in the Annual Report]
[Contact: ATA Inc. CCG Investor Relations Phone: +(1) 646-213-1914 ATA Announces Results for First Fiscal Quarter 2010 BEIJING, September 3, 2009 ATA Inc. (ATA or the Company) (NASDAQ: ATAI), the leading provider of computer-based testing and testing-related services in China, today announced its unaudited financial results for its first quarter ended June 30, 2009 (First Quarter 2010). First Quarter] [Form 6-K September 3, 2009 ATA Inc. 8th Floor, Tower E x x n/a ATA Inc. Carl Yeung Carl Yeung Chief Financial Officer Description 99.1 Press Release dated September 3, 2009 6-K 1 htm_4254.htm LIVE FILING]
[Entry into Letter of Intent for Business Combination The consummation of the business combination is subject to, among other things, execution of a definitive agreement and required stockholder approval. There can be no assurance that a business combination will be consummated. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Resignation]
[Entry into Letter of Intent for Business Combination The consummation of the business combination is subject to, among other things, execution of a definitive agreement and required stockholder approval. There can be no assurance that a business combination will be consummated. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Resignation]
